Here are 11 key notes on orthopedic and spine device companies from the past week.
Johnson & Johnson acquired Orthotaxy, a privately-held developer of software-enabled surgery technologies, including a robotic-assisted surgery solution.
Medtronic reported $7.3 billion in third quarter 2018 revenue, a 1 percent increase over the same period last year.
Nexxt Spine reported the 250th implantation of its NEXXT MATRIXX System.
Orthopedic surgical navigation manufacturer OrthAlign passed a significant clinical milestone, with 75,000 navigation-assisted joint arthroplasty cases performed with OrthAlign technology.
Integra LifeSciences agreed to lease a 110,000-square-foot portion of an industrial building at Cabot Business Park in Mansfield, Mass.
Life Spine launched a new website to provide hospitals, health systems and surgeons more information on its Micro-Invasive Expandable products.
Stryker ranked No. 16 out of 100 on Fortune Magazine's Best Companies to Work For list.
Mazor Robotics CEO Ori Hadomi spoke on several topics during the 2017 earnings call earlier this week, including the future for both the Renaissance and Mazor X systems.
Simplify Medical concluded enrollment for its U.S. investigational device exemption trial testing the Simplify cervical artificial disc.
Enrollment completed for Spineology's SCOUT clinical trial.
After crossing the 95 percent threshold in Vexim, Stryker plans to file a public buy-out offer followed by a squeeze-out for outstanding Vexim shares.